1. Home
  2. PDSB vs MATH Comparison

PDSB vs MATH Comparison

Compare PDSB & MATH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PDSB
  • MATH
  • Stock Information
  • Founded
  • PDSB 2005
  • MATH 2015
  • Country
  • PDSB United States
  • MATH Hong Kong
  • Employees
  • PDSB N/A
  • MATH N/A
  • Industry
  • PDSB Biotechnology: Pharmaceutical Preparations
  • MATH Finance/Investors Services
  • Sector
  • PDSB Health Care
  • MATH Finance
  • Exchange
  • PDSB Nasdaq
  • MATH Nasdaq
  • Market Cap
  • PDSB 58.7M
  • MATH 64.9M
  • IPO Year
  • PDSB N/A
  • MATH N/A
  • Fundamental
  • Price
  • PDSB $1.16
  • MATH $1.88
  • Analyst Decision
  • PDSB Strong Buy
  • MATH
  • Analyst Count
  • PDSB 3
  • MATH 0
  • Target Price
  • PDSB $10.00
  • MATH N/A
  • AVG Volume (30 Days)
  • PDSB 794.1K
  • MATH 100.1K
  • Earning Date
  • PDSB 03-27-2025
  • MATH 10-31-2024
  • Dividend Yield
  • PDSB N/A
  • MATH N/A
  • EPS Growth
  • PDSB N/A
  • MATH N/A
  • EPS
  • PDSB N/A
  • MATH 0.17
  • Revenue
  • PDSB N/A
  • MATH $31,399,049.00
  • Revenue This Year
  • PDSB $5,518.68
  • MATH N/A
  • Revenue Next Year
  • PDSB N/A
  • MATH N/A
  • P/E Ratio
  • PDSB N/A
  • MATH $11.45
  • Revenue Growth
  • PDSB N/A
  • MATH 291.58
  • 52 Week Low
  • PDSB $1.05
  • MATH $0.80
  • 52 Week High
  • PDSB $4.42
  • MATH $2.78
  • Technical
  • Relative Strength Index (RSI)
  • PDSB 40.47
  • MATH 51.05
  • Support Level
  • PDSB $1.19
  • MATH $1.65
  • Resistance Level
  • PDSB $1.41
  • MATH $2.10
  • Average True Range (ATR)
  • PDSB 0.10
  • MATH 0.16
  • MACD
  • PDSB -0.01
  • MATH -0.01
  • Stochastic Oscillator
  • PDSB 27.63
  • MATH 51.11

About PDSB PDS Biotechnology Corporation

PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.

About MATH Metalpha Technology Holding Limited

Metalpha Technology Holding Ltd is a digital asset focused wealth management company. The company predominantly generates revenue from the execution of cryptocurrency-related transactions, which includes the issuance of derivative products to over-the-counter (OTC) clients and its proprietary trading activities. It has partnered with a crypto exchange to provide crypto derivative market-making services for its clients, facilitating the trading of crypto derivative products. In addition, the company also engages in providing traditional financial derivative products, and asset management services. It operates in a single segment which is the trading of proprietary digital assets and derivative contracts, and derives a majority of its revenue from Hong Kong.

Share on Social Networks: